Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,572 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of participatory organizational interventions on mental health and work performance: A protocol for systematic review and meta-analysis.
Iida M, Sakuraya A, Imamura K, Asaoka H, Arima H, Ando E, Inoue A, Inoue R, Iwanaga M, Eguchi H, Otsuka Y, Kobayashi Y, Komase Y, Kuribayashi K, Sasaki N, Tsuno K, Hino A, Watanabe K, Ebara T, Shimazu A, Kawakami N, Tsutsumi A. Iida M, et al. Among authors: eguchi h. J Occup Health. 2024 May 28:uiae028. doi: 10.1093/joccuh/uiae028. Online ahead of print. J Occup Health. 2024. PMID: 38805736 Free article.
Skeletal Myoblast Cells Enhance the Function of Transplanted Islets in Diabetic Mice.
Kado T, Tomimaru Y, Kobayashi S, Harada A, Sasaki K, Iwagami Y, Yamada D, Noda T, Takahashi H, Kita S, Shimomura I, Miyagawa S, Doki Y, Eguchi H. Kado T, et al. Among authors: eguchi h. J Diabetes Res. 2024 May 17;2024:5574968. doi: 10.1155/2024/5574968. eCollection 2024. J Diabetes Res. 2024. PMID: 38800586 Free PMC article.
ASO Visual Abstract: Results of a Randomized Clinical Study of Gemcitabine Plus Nab-Paclitaxel versus Gemcitabine Plus S-1 as Neoadjuvant Chemotherapy for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma (RCT, CSGO-HBP-015).
Yamada D, Kobayashi S, Takahashi H, Iwagami Y, Akita H, Asukai K, Shimizu J, Yamada T, Tanemura M, Yokoyama S, Tsujie M, Asaoka T, Takeda Y, Morimoto O, Tomokuni A, Doki Y, Eguchi H. Yamada D, et al. Among authors: eguchi h. Ann Surg Oncol. 2024 May 25. doi: 10.1245/s10434-024-15479-3. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38796587 No abstract available.
Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models.
Kawabata-Iwakawa R, Iwasa N, Satoh K, Colinge J, Shimada M, Takeuchi S, Fujiwara H, Eguchi H, Oishi T, Sugiyama T, Suzuki M, Hasegawa K, Fujiwara K, Nishiyama M. Kawabata-Iwakawa R, et al. Among authors: eguchi h. Int J Clin Oncol. 2024 May 20. doi: 10.1007/s10147-024-02552-w. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38767719
High-mobility group box 1 fragment ameliorates chronic pancreatitis induced by caerulein in mice.
Hokkoku D, Sasaki K, Kobayashi S, Shimbo T, Kitayama T, Yamazaki S, Yamamoto Y, Ouchi Y, Imamura H, Kado T, Toya K, Fujii W, Iwagami Y, Yamada D, Tomimaru Y, Noda T, Takahashi H, Tamai K, Doki Y, Eguchi H. Hokkoku D, et al. Among authors: eguchi h. J Gastroenterol. 2024 May 10. doi: 10.1007/s00535-024-02112-z. Online ahead of print. J Gastroenterol. 2024. PMID: 38727823
ASO Author Reflections: Which was the Better Regimen (Gemcitabine Plus Nab-Paclitaxel Versus Gemcitabine Plus S-1) as Neoadjuvant Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma (R/BR-PDAC)?
Yamada D, Kobayashi S, Takahashi H, Iwagami Y, Akita H, Asukai K, Shimizu J, Yamada T, Tanemura M, Yokoyama S, Tsujie M, Asaoka T, Takeda Y, Morimoto O, Tomokuni A, Doki Y, Eguchi H. Yamada D, et al. Among authors: eguchi h. Ann Surg Oncol. 2024 May 9. doi: 10.1245/s10434-024-15244-6. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38722422 No abstract available.
1,572 results